3.4Impact Factor
9.9CiteScore
20 daysTime to First Decision

Vaccines, Volume 5, Issue 3

September 2017 - 15 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

Select all

Review

8 Citations

7,871 Views

24 Pages

Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns

Federica Riccardo,
Aline Réal,
Claudia Voena,
Roberto Chiarle,
Federica Cavallo and
Giuseppina Barutello

Vaccines2017, 5(3), 20;https://doi.org/10.3390/vaccines5030020

1 August 2017

The continuous evolution in preventive medicine has anointed vaccination a versatile, human-health improving tool, which has led to a steady decline in deaths in the developing world. Maternal immunization represents an incisive step forward for the...

Full Article

Article

4 Citations

5,768 Views

16 Pages

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

Harshad P. Patil,
José Herrera Rodriguez,
Jacqueline De Vries-Idema,
Tjarko Meijerhof,
Henderik W. Frijlink,
Wouter L. J. Hinrichs and
Anke Huckriede

Vaccines2017, 5(3), 19;https://doi.org/10.3390/vaccines5030019

27 July 2017

Adjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosa...

Full Article

Review

57 Citations

14,564 Views

8 Pages

Egg-Independent Influenza Vaccines and Vaccine Candidates

Ilaria Manini,
Claudia Maria Trombetta,
Giacomo Lazzeri,
Teresa Pozzi,
Stefania Rossi and
Emanuele Montomoli

Vaccines2017, 5(3), 18;https://doi.org/10.3390/vaccines5030018

18 July 2017

Vaccination remains the principal way to control seasonal infections and is the most effective method of reducing influenza-associated morbidity and mortality. Since the 1940s, the main method of producing influenza vaccines has been an egg-based pro...

Full Article

Article

10 Citations

4,874 Views

14 Pages

Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population

Ivan Sanz,
Silvia Rojo,
Sonia Tamames,
José María Eiros and
Raúl Ortiz de Lejarazu

Vaccines2017, 5(3), 17;https://doi.org/10.3390/vaccines5030017

17 July 2017

Avian influenza viruses are currently one of the main threats to human health in the world. Although there are some screening reports of antibodies against these viruses in humans from Western countries, most of these types of studies are conducted i...

Full Article

Article

27 Citations

6,741 Views

15 Pages

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection

Abhijeet A. Bakre,
Jennifer L. Harcourt,
Lia M. Haynes,
Larry J. Anderson and
Ralph A. Tripp

Vaccines2017, 5(3), 16;https://doi.org/10.3390/vaccines5030016

3 July 2017

Respiratory Syncytial Virus (RSV) infects respiratory epithelial cells and deregulates host gene expression by many mechanisms including expression of RSV G protein (RSV G). RSV G protein encodes a central conserved region (CCR) containing a CX3C mot...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Vaccines - ISSN 2076-393X

Imprint

Download Flyer